相关实验视频
Updated: May 6, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
干预措施的有效性,以减少药物管理期间的中断:系统性审查
Wei Zhang1, Yuying Zhang1, Zihan Guo1
1School of Nursing, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Worldviews on evidence-based nursing
|July 27, 2025
概括
预防策略可以减少药物管理期间的外部中断,但护士对护士的中断仍然存在. 建议采用综合方法,以提高患者的安全性和减少药物错误.
科学领域:
- 护理 护理 护理
- 患者安全 患者安全
- 医疗保健的质量 医疗保健的质量
背景情况:
- 在服用药物时出现的药物错误对患者的安全构成重大风险.
- 干扰是这些药物错误的主要原因,不成比例地影响护士.
- 为了减轻这些干扰,已开发出许多干预措施.
研究的目的:
- 系统地审查和评估旨在最大限度地减少药物管理中断的干预措施的有效性.
- 评估针对护士中断的预防和响应策略.
主要方法:
- 对多个数据库进行了全面的系统搜索.
- 包括14项研究,包括随机对照试验和准实验设计.
- 测量的主要结果是中断率和药物错误率;元分析因异质性而被排除.
主要成果:
- 预防性干预,如"不中断背心"和宣传活动,显示出减少外部中断的潜力.
- 护士对护士的中断仍然是一个重大挑战.
- 响应式策略在减少中断方面取得了有限的成功,但提高了护士的管理能力.
- 对药物错误率的直接影响是不确定的.
结论:
- 预防策略对外部干扰是有效的,但对于护士对护士的干扰需要改进.
- 结合预防和响应性干预的多方面的方法对于提高药物安全至关重要.
- 需要进一步的有针对性的干预措施来解决持续的护士对护士的中断问题.
相关概念视频
Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Dosage Interval and Administration Route: Determination Methods
572
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
572
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
144
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
144
Modified-Release Drug Delivery Systems: Overview
243
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
243
Modified-Release Drug Delivery Systems: Influencing Factors
215
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
215
Oral Drug Delivery Systems: Continuous-Release Systems
319
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
319

